Robert E. Waltermire, Senior VP, Chief Pharma Development at MADRIGAL PHARMACEUTICALS, INC. (MDGL), sold 2,000 shares at $285.00 ($570K) on 2024-06-12, disclosed to the SEC on 2024-06-14.
Open-market sale of $570k MDGL by Senior VP, Chief Pharma Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| MDGL | SELL | 2025-01-27 | $35K | — | Filing → |
| MDGL | SELL | 2025-01-17 | $242K | — | Filing → |
| MDGL | SELL | 2024-06-18 | $532K | — | Filing → |